CIAM
IRON icon

Caitong International Asset Management’s Disc Medicine IRON Stock Holding History

Caitong International Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,001
Closed -$64K – 3221
2026
Q1 		$64K Buy
1,001
+769
+331% +$53.4K 0.01% 703
2025
Q4 		$18.4K Buy
232
+172
+287% +$14.5K ﹤0.01% 1011
2025
Q3 		$3.96K Buy
60
+57
+1,900% +$3.39K ﹤0.01% 1274
2025
Q2 		$159 Sell
3
-944
-100% -$44.3K ﹤0.01% 1817
2025
Q1 		$47K Buy
947
+940
+13,429% +$52.3K 0.04% 516
2024
Q4 		$444 Buy
+7
New +$405 ﹤0.01% 1484

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caitong International Asset Management's IRON Position: Q2 2026 in Review

Caitong International Asset Management sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 1,001 shares — an estimated $64K sold.

Caitong International Asset Management first reported a position in IRON in Q4 2024 and held it in 6 quarters. The position peaked at $64K in Q1 2026. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Caitong International Asset Management reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,001 Disc Medicine shares in Q2 2026, an estimated $64K.
  • Caitong International Asset Management first reported a position in Disc Medicine in Q4 2024 and held it in 6 quarters.
  • Caitong International Asset Management's Disc Medicine position peaked at $64K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.